Status:
COMPLETED
Deep Diaphragmatic Breathing: Neurobiological and Anti-inflammatory Effects
Lead Sponsor:
Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo
Collaborating Sponsors:
Centro Studi Psicoterapia Neo-Funzionale
Conditions:
Unrecognized Condition
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
The exposure to acute and\\or chronic stress can produce an activation of sympathetic nervous system (SNS), leading to an increased level of cortisol and pro-inflammatory cytokines. The mind-body tech...
Detailed Description
Life's dynamics in modern societies expose the individuals to high level of suffering and stress, which can affect both psychological and physiological well-being. Numerous scientific evidences showed...
Eligibility Criteria
Inclusion
- Men and women aging between 18 and 55;
- Able to understanding and signing the informed consent;
Exclusion
- a current or lifetime diagnosis of any psychiatric disorders
- a past or present of drug abuse or drug addiction (including nicotine)
- chronic inflammation diseases
- Taking medicines active on the immune system (antibiotics, anti-histamines, corticosteroids, psychotropic substances) during the 2 weeks prior to the operation;
- Intense physical activities (at least 1h\\day);
- Intelligence Quotient less than 65
- BMI more than 40
- serious infections (such as HIV, hepatitis B and C)
- cancer in the previous 6 months
- regular use of anti-inflammatory drugs for more than 15 days/month
- Participation to other clinical trials;
Key Trial Info
Start Date :
February 24 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2021
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT04102813
Start Date
February 24 2020
End Date
September 30 2021
Last Update
October 28 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unit of Psychiatry
Palermo, PA, Italy, 90100